Flamel Technologies SA (NASDAQ:FLML)
| 13.61 Data as of 2:13pm ET |  +0.10 / +0.74%Today’s Change | 5.30 Today|||52-Week Range 15.75 | +69.07% Year-to-Date |
Latest FLML News | Press Releases
Today’s Trading
| Previous close | 13.51 |
| Today’s open | 13.41 |
| Day’s range | 12.89 - 14.21 |
| Volume | 196,532 |
| Average volume (3 months) | 195,391 |
| Market cap | $530.8M |
| Dividend yield | -- |
Data as of 1:57pm ET, 07/30/2014
Growth & Valuation
| Earnings growth (last year) | -1,200.92% |
| Earnings growth (this year) | +71.48% |
| Earnings growth (next 5 years) | +218.00% |
| Revenue growth (last year) | -13.92% |
| P/E ratio | NM |
| Price/Sales | 9.12 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ASPXAuspex Pharmaceutica... | -0.78 | -3.86% |
| VTLVital Therapies Inc | -1.05 | -4.08% |
| RPTPRaptor Pharmaceutica... | +0.98 | +12.05% |
| ARRYArray Biopharma Inc | +0.17 | +4.18% |
Data as of 2:15pm ET, 07/30/2014
Financials
| Next reporting date | November 17, 2014 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $22.5M |
| Annual profit (last year) | -$43.0M |
| Net profit margin | -191.26% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters --, -- |
Forecasts
.
